Comparative effectiveness of ramosetron for preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis Hyun Jin SongHyun-Ju SeoHeejeong Son Review 15 August 2016 Pages: 1289 - 1301
First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis Yanli ZhuangCesar CalderonZhenhua Xu Clinical Trial 11 August 2016 Pages: 1303 - 1310
Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials Xue-biao WeiLei JiangYuan-hui Liu Pharmacodynamics 01 October 2016 Pages: 1311 - 1318
Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland Ewa StawowczykPaweł KawalecAndrzej Pilc Pharmacoeconomics Open access 06 August 2016 Pages: 1319 - 1325
Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese Wu-Tao ZengQing XuZhi-Sheng Yang Pharmacogenetics 04 August 2016 Pages: 1327 - 1334
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson’s patients M FerrariC ComiM Cosentino Pharmacogenetics 06 August 2016 Pages: 1335 - 1341
Use of population approach non-linear mixed effects models in the evaluation of biosimilarity of monoclonal antibodies Joannes A. A. ReijersT. van DongeJ. Stevens Pharmacokinetics and Disposition Open access 11 August 2016 Pages: 1343 - 1352
Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs Yohei KoyaShinya UchidaTsutomu Kotegawa Pharmacokinetics and Disposition Open access 05 August 2016 Pages: 1353 - 1361
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction Mari FihlmanTuija HemmiläTeijo I. Saari Pharmacokinetics and Disposition 10 August 2016 Pages: 1363 - 1371
Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia Naïm BouazzaZoubir DjeradaMichel Polak Pharmacokinetics and Disposition 25 August 2016 Pages: 1373 - 1379
Adherence to antidepressants among women and men described with trajectory models: a Swedish longitudinal study Ann-Charlotte MårdbyLinus SchiölerAnna K. Jönsson Pharmacoepidemiology and Prescription 03 August 2016 Pages: 1381 - 1389
High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate Rehana JamaniEsther K. LeeUrban Emmenegger Pharmacoepidemiology and Prescription 25 August 2016 Pages: 1391 - 1399
Quantifying behavioural determinants relating to health professional reporting of medication errors: a cross-sectional survey using the Theoretical Domains Framework Mai AlqubaisiAntonella TonnaDerek Stewart Pharmacoepidemiology and Prescription 01 September 2016 Pages: 1401 - 1411
Tocilizumab and mesenteric arterial thrombosis: drug-drug interaction with anticoagulants metabolized by CYP 450 and/or by P-glycoprotein B. ClarivetP. RobinJ. L. Faillie Letter to the Editor 26 July 2016 Pages: 1413 - 1414
Cetrimide-induced oral mucositis: an unusual adverse drug reaction Giulio FortunaEnrico CerchioneMarianna Di Lorenzo Letter to the Editor 09 August 2016 Pages: 1415 - 1416